Реакция #89389

ord-22a8c44f2fdb428f8f104d8469b89f8f

Условия реакции

Подробные условия
See reaction.notes.procedure_details.

Методика

The title compound was prepared following the same general protocol as described for 2-(((2S,3R)-3-methyl-1-(5-methyl-2-(1-methyl-1H-pyrazol-4-yl)benzoyl)piperidin-2-yl)methyl)isoindoline-1,3-dione in Example A1, using 3-bromo-6-methylpicolinic acid. ESI-MS (m/z): 456, 458 [M]+[M+2]+.

Источник

DOI: 10.6084/m9.figshare.5104873.v1Патент: US09440982B2uspto-grants-2016_09